Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 39, 2019 - Issue 4
Submit an article Journal homepage
250
Views
10
CrossRef citations to date
0
Altmetric
Original Article

The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer

M. L. AlabdullahAcademic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK; ;Paediatric Surgery Department, Birmingham Children’s Hospital NHS Trust, Birmingham, UK; Correspondence[email protected]
,
D. A. AhmadDepartment of Histopathology, Division of Cancer and Stem cells, School of Medicine, University of Nottingham, Nottingham, UK;
,
P MoseleyDepartment of Oncology, Nottingham University Hospital, Nottingham, UK;
,
S. MadhusudanDepartment of Oncology, Nottingham University Hospital, Nottingham, UK; ;Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, UK
,
S ChanDepartment of Oncology, Nottingham University Hospital, Nottingham, UK;
&
E. RakhaDepartment of Histopathology, Division of Cancer and Stem cells, School of Medicine, University of Nottingham, Nottingham, UK;
Pages 522-528 | Published online: 04 Feb 2019

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yinghua Li & Jian Zhou. (2021) USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation. Cancer Management and Research 13, pages 3913-3924.
Read now

Articles from other publishers (9)

梦帆 刘. (2024) Research Progress of EIF4EBP1 in Tumors. Advances in Clinical Medicine 14:03, pages 909-915.
Crossref
Reem T. Attia, Menna A. Ewida, Eman Khaled, Sherif Ashraf Fahmy & Iten M. Fawzy. (2023) Newly Synthesized Anticancer Purine Derivatives Inhibiting p -EIF4E Using Surface-Modified Lipid Nanovesicles . ACS Omega 8:41, pages 37864-37881.
Crossref
Jacob P. Veenstra, Lucas Felipe Fernandes Bittencourt & Katherine M. Aird. (2022) The senescence-associated secretory phenotype in ovarian cancer dissemination. American Journal of Physiology-Cell Physiology 323:1, pages C125-C132.
Crossref
Yaoxiang Tang, Jiadi Luo, Yang Yang, Sile Liu, Hongmei Zheng, Yuting Zhan, Songqing Fan & Qiuyuan Wen. (2022) Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection. PLOS ONE 17:6, pages e0265465.
Crossref
Wen-Qian HuangYan Zou, Ying TianXiao-Feng MaQin-Yi ZhouZhen-Yu LiShao-Xin GongAi-Ping Wang. (2022) Mammalian Target of Rapamycin as the Therapeutic Target of Vascular Proliferative Diseases: Past, Present, and Future. Journal of Cardiovascular Pharmacology 79:4, pages 444-455.
Crossref
Pradnya R. Kamble, Ananya A. Breed, Apoorva Pawar, Grishma Kasle & Bhakti R. Pathak. (2022) Prognostic utility of the ovarian cancer secretome: a systematic investigation. Archives of Gynecology and Obstetrics 306:3, pages 639-662.
Crossref
Ruyu Pi, Yang Yang, Xiaoyi Hu, Hongyi Li, Houhui Shi, Yu Liu, Xi Wang, An Tong, Tianqi Lu, Yuquan Wei, Xia Zhao & Xiawei Wei. (2021) Dual mTORC1/2 inhibitor AZD2014 diminishes myeloid-derived suppressor cells accumulation in ovarian cancer and delays tumor growth. Cancer Letters 523, pages 72-81.
Crossref
Jiang Ruibin, Jin Bo, Wan Danying, Feng Jianguo & Gu Linhui. (2020) Cardamonin induces G2/M phase arrest and apoptosis through inhibition of NF-κB and mTOR pathways in ovarian cancer. Aging 12:24, pages 25730-25743.
Crossref
Peiqi Hao, Jiaojiao Yu, Richard Ward, Yin Liu, Qiao Hao, Su An & Tianrui Xu. (2020) Eukaryotic translation initiation factors as promising targets in cancer therapy. Cell Communication and Signaling 18:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.